"covid-19" prototype development of a thereaputic to treat covid-19.
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY2190018
- Awardee
-
Rigel Pharmaceuticals Inc. UEI X7MHPBCMHFM3
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $16,000,000
Award facts
- Contract value 97% obligated
- $16,500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$500,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $16,500,000 |
About this award
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $16.5 million Other Transaction Agreement to Rigel Pharmaceuticals Inc. to support the development of a therapeutic to treat COVID-19. The prototype effort will take place in South San Francisco, California through May 2023. No set-aside designation was applied to this award made under the "COVID-19" PROTOTYPE DEVELOPMENT OF A THEREAPUTIC TO TREAT COVID-19 solicitation. As the Joint PEO Chemical and Biological Defense works to develop medical countermeasures against pandemic threats, this award aims to deliver a COVID-19 therapeutic to the agency's portfolio by its completion date.
Quick answers
Who was awarded contract W911QY2190018?
W911QY2190018 was awarded to Rigel Pharmaceuticals Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on January 29, 2021.
How much is contract W911QY2190018 worth?
The government has obligated $16,000,000 on W911QY2190018. Its current value, with exercised options, is $16,500,000.
Which agency awarded contract W911QY2190018?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2190018, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY2190018 competed?
The extent of competition for W911QY2190018 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award